ArticleMacromolecular rapid communications2026
Exploring a Ugi-Mediated Polymerization-Induced Self-Assembly Approach to Peptoid Particles.
Article in Macromolecular rapid communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
This work investigates the synthesis of polypeptoid nanoparticles through Ugi-mediated polymerization-induced self-assembly (U-PISA), combining aqueous Ugi four-component polycondensation with PEG-based stabilization. Polypeptoid nano-objects were produced directly from amino acid-derived building blocks via a one-pot process under mild, open-air conditions. The effects of PEG molar mass and feed composition on particle formation and morphology were systematically examined, providing access to tunable spherical and worm-like nanostructures. The in situ formation of amphiphilic PEG-polypeptoid species suggests that nanoparticle formation proceeds through a PISA-like mechanism. However, the step-growth nature of the Ugi polycondensation implies that both PEG-functionalized and unconjugated polypeptoid chains may participate in nanoparticle assembly and stabilization. These results demonstrate that multicomponent polymerizations, such as Ugi polymerization, can be integrated into a PISA strategy, offering a simple route to polypeptoid nanoparticles with tunable morphologies and potential biomedical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.